Loading...
Loading...
India's nilotinib imports from BRAZIL total $165.4K across 19 shipments from 11 foreign suppliers. TORRENT DO BRASIL LTDA leads with $52.1K in import value; the top 5 suppliers together control 76.4% of this origin. Leading Indian buyers include TORRENT PHARMACEUTICALS LTD. This corridor reflects India's pharmaceutical import demand for nilotinib — a diversified sourcing base with multiple active suppliers from BRAZIL.

TORRENT DO BRASIL LTDA is the leading Nilotinib supplier from BRAZIL to India, with import value of $52.1K across 3 shipments. The top 5 suppliers — TORRENT DO BRASIL LTDA, DERMA & DERMO COM DE PROD DERMAE FARMA, DERMA & DERMO COM. PRODS. DERM. FARM. LIMITEDA (AMHO) BRAZIL 30049099 1 1 Nilotinib Capsules 150 mg 150milligram (mg) (TASIGNA) 120 NOS 38.666667 USD 490106.44 70183.3 - 10 0 - 0 0 65282.2 0 2347162 28/02/2024 H 0903011107 MSN LABORATORIES PRIVATE LIMITED DERMA & DERMO COM. PRODS. DERM. FARM. LIMITEDA (AMHO), GLOBAL ORGANIZACAO FARMACEUTICA LTDA, GLOBAL ORGANIZACAO FARMACEUTICA LTD — collectively account for 76.4% of total import value from this origin.
Ranked by import value (USD) · Indian Customs (DGFT) data
| # | Supplier | Value (USD) | Shipments | Share |
|---|---|---|---|---|
| 1 | TORRENT DO BRASIL LTDA | $52.1K | 3 | 31.5% |
| 2 | DERMA & DERMO COM DE PROD DERMAE FARMA | $23.9K | 2 | 14.4% |
| 3 | DERMA & DERMO COM. PRODS. DERM. FARM. LIMITEDA (AMHO) BRAZIL 30049099 1 1 Nilotinib Capsules 150 mg 150milligram (mg) (TASIGNA) 120 NOS 38.666667 USD 490106.44 70183.3 - 10 0 - 0 0 65282.2 0
2347162 28/02/2024 H 0903011107 MSN LABORATORIES PRIVATE LIMITED DERMA & DERMO COM. PRODS. DERM. FARM. LIMITEDA (AMHO) | $17.6K | 1 | 10.6% |
| 4 | GLOBAL ORGANIZACAO FARMACEUTICA LTDA | $16.6K | 4 | 10.0% |
| 5 | GLOBAL ORGANIZACAO FARMACEUTICA LTD | $16.3K | 1 | 9.9% |
| 6 | DR. REDDYS FARMACEUTICA DO BRASIL LIMITEDA | $10.4K | 1 | 6.3% |
| 7 | ACCORD FARMACEUTICA LTDA. | $9.6K | 1 | 5.8% |
| 8 | DR.REDDY'S FARMACEUTICA DO BRASIL LTDA | $8.7K | 2 | 5.2% |
| 9 | GLOBAL FARMA - GLOBAL ORGANIZACAO FARMACEUTICA LTD | $5.4K | 1 | 3.3% |
| 10 | M/S. GLOBAL ORGANIZACAO FARMACEUTIC | $4.8K | 1 | 2.9% |
| 11 | CAMBER FARMACEUTICA LTDA, | $120 | 2 | 0.1% |
Ranked by import value (USD)
| # | Buyer | Value (USD) | Shipments | Share |
|---|---|---|---|---|
| 1 | TORRENT PHARMACEUTICALS LTD | $52.1K | 3 | 31.5% |
| 2 | TEYRO LABS PRIVATE LIMITED | $23.9K | 2 | 14.4% |
| 3 | MSN LABORATORIES PRIVATE LIMITED | $17.6K | 1 | 10.6% |
| 4 | CIPLA LIMITED | $16.6K | 4 | 10.0% |
| 5 | SITEC LABS LIMITED | $16.3K | 1 | 9.9% |
| 6 | DR.REDDY'S LABORATORIES LIMITED | $10.4K | 1 | 6.3% |
| 7 | LAMBDA THERAPEUTIC RESEARCH LIMITED | $9.6K | 1 | 5.8% |
| 8 | DR.REDDY'S LABORATORIES LTD | $8.7K | 2 | 5.2% |
| 9 | GLENMARK PHARMACEUTICALS LTD | $5.4K | 1 | 3.3% |
| 10 | GLENMARK PHARMACEUTICALS LIMITED | $4.8K | 1 | 2.9% |
| 11 | HETERO LABS LIMITED | $120 | 2 | 0.1% |
Answers based on Indian Customs (DGFT) import records compiled by TransData Nexus
The top Nilotinib suppliers from BRAZIL to India include TORRENT DO BRASIL LTDA, DERMA & DERMO COM DE PROD DERMAE FARMA, DERMA & DERMO COM. PRODS. DERM. FARM. LIMITEDA (AMHO) BRAZIL 30049099 1 1 Nilotinib Capsules 150 mg 150milligram (mg) (TASIGNA) 120 NOS 38.666667 USD 490106.44 70183.3 - 10 0 - 0 0 65282.2 0 2347162 28/02/2024 H 0903011107 MSN LABORATORIES PRIVATE LIMITED DERMA & DERMO COM. PRODS. DERM. FARM. LIMITEDA (AMHO). The leading supplier is TORRENT DO BRASIL LTDA with import value of $52.1K USD across 3 shipments. India imported Nilotinib worth $165.4K USD from BRAZIL in total across 19 shipments.
India imported Nilotinib worth $165.4K USD from BRAZIL across 19 shipments. Data is from Indian Customs (DGFT) records. Values are in USD.
The main Indian buyers of Nilotinib sourced from BRAZIL include TORRENT PHARMACEUTICALS LTD, TEYRO LABS PRIVATE LIMITED, MSN LABORATORIES PRIVATE LIMITED. The largest buyer is TORRENT PHARMACEUTICALS LTD with $52.1K in imports across 3 shipments.
The total value of Nilotinib imports from BRAZIL to India is $165.4K USD, across 19 shipments and 11 foreign suppliers. Data source: Indian Customs (DGFT).
Data sourced from Indian Customs (DGFT) records. Verify regulatory and trade status with the agencies above.
Pharmaceutical Export-Import Analyst & Trade Intelligence Expert
Suresh Sormare is a pharmaceutical export-import analyst with deep expertise in Indian Customs (DGFT) data, HS code classification, and global pharmaceutical supply chains. His analysis covers 10M+ shipment records across 150+ countries and is used by manufacturers, procurement agencies, and trade consultants worldwide. Suresh specializes in identifying verified suppliers and buyers from customs records, mapping bilateral pharmaceutical trade corridors, analyzing tariff structures and regulatory frameworks across 170+ destination markets, and benchmarking competitive positioning for finished pharmaceutical formulations. His methodology combines granular customs transaction data with regulatory intelligence from FDA, EMA, WHO, CDSCO, and 40+ national drug authorities to deliver actionable trade insights for the pharmaceutical formulations sector.
linkedin.com/in/sureshsormareAll trade data is sourced from Indian Customs (DGFT) official shipping bill records — the authoritative government database for India's pharmaceutical trade. Each verified record contains exporter name, consignee (buyer) name, detailed product description, quantity, declared FOB value (USD), port of loading, destination country, and shipment date.
Government-Sourced Data
Official DGFT customs records
Transparent Methodology
Calculations fully disclosed above
19 Verified Shipments
11 suppliers, 11 buyers tracked
Expert-Reviewed
By pharmaceutical trade specialists